Only as laboratory reagents sold to researchers, and only if nothing in the ad or on the landing page implies human use. Meta prohibits ads that promote the sale or use of unsafe substances, products or supplements. Google prohibits unapproved substances outright. A research use only line does not save a page that reads as a treatment.
This page quotes the platforms' own published policy text and the FDA's own letters, with links. It contains no workarounds, and it is not going to, because the workarounds are what get accounts permanently disabled. If you want the offer rather than the policy, that is compliant paid acquisition for research peptide brands.
What this page is not. Not legal advice, not regulatory advice, and not a compliance opinion on any specific product. Advertising policies change without notice and the versions quoted here were read on 15 September 2026. Confirm the current text at the links before you act on any of it, and use counsel for anything touching FDA jurisdiction.
What do Meta and Google actually say?
Most of what circulates about peptide advertising is secondhand. Here is the published text, quoted and linked, so you can check it yourself.
| Platform and policy | The published line | What it means for a research peptide advertiser |
|---|---|---|
| Meta Drugs and Pharmaceuticals |
"Advertisers can't run ads that promote the sale or use of illicit or recreational drugs, or other unsafe substances, products or supplements" | The prohibition is on promoting the sale or use. A page that describes a compound's specification is different from a page that promotes its use. The words that describe use are the risk. |
| Meta Drugs and Pharmaceuticals |
Prohibits ads that "Solicit, buy, sell, trade, donate or gift (such as freebies)" or "Encourage the consumption of illicit, recreational, or other potentially unsafe drugs, products or supplements" | "Encourage the consumption" is the operative phrase. Free samples, bundle offers and anything that reads as an invitation to take the product land here. |
| Meta Health and Wellness |
Prohibits "Claims (including those from health professionals or health organizations) to cure, heal, or eliminate" listed incurable diseases; prohibits "clickbait tactics in a health, weight loss, or weight gain context, such as sensational language with exaggerated or extreme claims, or promises of specific outcomes within a set timeframe" | Applies even where a product is otherwise permitted. A borrowed claim from a study or a clinician is still a claim under this standard. |
| Meta Advertising Standards, review |
"This review process may include the specific components of an ad, such as images, video, text and targeting information, as well as an ad's associated landing page or other destinations"; "ads may be reviewed again, including after they are live" | The landing page is in scope. Editing the page after approval puts it back in the queue. There is no state in which the page is done being reviewed. |
| Google Healthcare and medicines |
Routes unapproved products to the Unapproved substances policy; separately restricts prescription drug terms, requires certification for pharmaceutical manufacturers, and prohibits "Promotion of speculative and/or experimental medical treatments" | Research compounds sit closest to "speculative and/or experimental" the moment a page connects them to a human outcome. |
| Google Unapproved substances |
"Google doesn't allow the promotion of certain products, regardless of any claims of legality"; includes "Herbal and dietary supplements with active pharmaceutical or dangerous ingredients", "Products that imply they are as effective as prescription drugs or controlled substances", and "Products that have been subject to any government or regulatory action or warning" | "Regardless of any claims of legality" is the sentence that ends most arguments. Legal to sell is not the same as permitted to advertise. |
| Google Unapproved pharmaceuticals and supplements |
"This is not an exhaustive list, and is intended to provide examples of the types of content monitored" | Not being on the list is not clearance. The list is illustrative and it moves. |
| Google Abusing the ad network |
"Manipulation of ad components like text, image, videos, domain, or subdomains in an attempt to bypass detection or enforcement action is not allowed"; "Engaging in practices that circumvent or interfere with Google's advertising systems and processes, or attempting to do so is not allowed" | This is the policy that turns a survivable rejection into an account-level enforcement. Every workaround sold in this niche is described in that sentence. |
primary All eight rows are the platforms' own published policy pages, read 15 September 2026. Meta's standards are reorganised periodically; at the time of reading, unsafe substances and supplements were covered under Drugs and Pharmaceuticals, not under a standalone Unsafe Substances page.
Which phrase families get research-peptide ads rejected, and why?
Rejections in this category almost never turn on the compound. They turn on whether the page reads as a product for people. The FDA has said this more clearly than either platform. In a warning letter dated 12 December 2025:
The same letter sets out the legal test: the products "are drugs under section 201(g)(1) of the FD&C Act ... because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or intended to affect the structure or any function of the body." Intended use is inferred from evidence, and the evidence is your website.
In an August 2026 letter the agency named three evidence categories explicitly: product-page claims describing outcomes in people, educational blog posts comparing compounds and discussing effects, and ancillary products sold alongside, specifically bacteriostatic water offered together with a preparation guide and a dosing calculator. None of those three is the disclaimer. All three are the rest of the site.
So the families below are not a list of banned words to swap out. They are the evidence categories a reviewer and a regulator both read, and the only durable fix is that the claim is not made anywhere.
| Phrase family | What it looks like | Why it is fatal | What belongs there instead |
|---|---|---|---|
| Outcome claims | Any sentence in which the compound does something measurable to a person or a body | Direct evidence of intended use under FD&C 201(g)(1); a "structure or function" claim on its face | Nothing. There is no compliant version of this sentence on a research reagent page |
| Disease and condition words | Treats, reverses, manages, prevents, or the name of a condition anywhere near the product | Meta's Health and Wellness standard prohibits cure, heal or eliminate claims outright; Google's unapproved substances policy covers products marketed as safe or effective for preventing or treating disease | The compound's mechanism class stated as chemistry, with no subject |
| Dosing and administration | Protocols, milligram figures, reconstitution steps, cycle lengths, calculators, injection guidance | The FDA named a preparation guide and dosing calculator as evidence of intended human use in August 2026 | Storage temperature, solubility, handling and stability data for a laboratory |
| Prescription equivalence | Comparisons to an approved drug, "pharmaceutical grade" used as a benefit, "the same as" framing | Google's unapproved substances policy names "Products that imply they are as effective as prescription drugs or controlled substances" | Purity percentage and the analytical method that produced it |
| Consumer-shaped merchandising | Bundles, freebies, subscribe-and-save, injection supplies sold with the compound, anything that only makes sense for a person | Meta prohibits ads that solicit, gift or "encourage the consumption" of unsafe substances or supplements; the FDA cited exactly this bundling | Quantity, format, lot, and a purchase flow that expects an institution |
| Borrowed proof | Testimonials, before-and-after images, clinician endorsements, trial results quoted as a selling point | Meta's Health and Wellness standard applies to claims "including those from health professionals or health organizations"; the FTC holds a marketer "equally responsible for the accuracy of claims suggested or reasonably implied" | A certificate of analysis and a literature citation with no implied recommendation |
| Timeframe clickbait | Results in a set number of days or weeks, urgency framed around an outcome | Meta names "promises of specific outcomes within a set timeframe without disclaimers or qualifiers" as a prohibited clickbait tactic | Lead time and shipping, which is the only timeframe a reagent buyer cares about |
| Body-image framing | Pinched fat, body-part close-ups, appearance-negative questions | Meta prohibits "statements of inferiority about physical appearance" and specific weight-loss imagery | The compound, the vial, the label, the certificate |
The fourth column is not a euphemism for the first. Each row's honest fix is to delete the claim, not to soften it. If a business cannot describe what it sells without one of these families, the constraint is the business model, not the copywriting.
The FTC point that catches careful advertisers. Its Health Products Compliance Guidance states that "a marketer is equally responsible for the accuracy of claims suggested or reasonably implied in advertising," and that a disclaimer "won't cure an otherwise deceptive ad, particularly where the deception concerns claims about the health-related benefits of a product." Implication counts. A page can pass a keyword scan and still make the claim.
What does a review-safe product page contain?
A page built for review reads like a specification sheet a laboratory would purchase from, because that is what it should be. Ten things, in roughly this order.
Identity, above the fold
Compound name, CAS number where one exists, molecular formula and molecular weight. The first thing on the page is what the thing is, not what it does.
The research use statement, at the top
Not in the footer, not in eight-point grey. It belongs beside the product name, where the reviewer reads first and where the FDA's "whole page" test lands.
Purity and the method behind it
A percentage is a claim unless the analytical method is named. HPLC and mass spec results, with the date and the lot they belong to.
A downloadable certificate of analysis
Per lot, dated, from a named laboratory. This is the single strongest trust asset in the category and it carries no regulatory risk, because it is data rather than a promise.
Format, quantity and lot
Vial size, fill, physical form, packaging. Concrete and boring.
Storage, stability and handling
Temperature, light, solubility, shelf life. Laboratory handling information, written for a laboratory. Nothing about preparing anything for a person.
Safety data
An SDS, hazard statements, and disposal guidance. A page with an SDS reads as a chemical supplier; a page without one reads as a shop.
A buyer who is an institution
Checkout that asks for an organisation and a shipping address that is a facility. If the flow is built for a consumer, the page is a consumer page whatever it says.
Literature citations without a recommendation
References are fine. References arranged to suggest a result are the claim again, wearing a lab coat.
Nothing in the cart that implies a person
No injection supplies, no bacteriostatic water bundled with the compound, no calculator, no guide. The FDA named that combination specifically, in writing, in 2026.
Then apply the test that matters: read the page, the blog, the FAQ, the email flow and the social account as one document, because that is how both the reviewer and the regulator read them. The product page is usually the cleanest asset a peptide brand owns. The blog is usually what gets it disabled.
Want to know which of these your pages trip before you spend on them?
Paste an ad or a landing page and get a written read on which policy lines it touches and what has to change. No account access, nothing installed, and we will tell you plainly if the answer is that it cannot be advertised.
Get the ad rejection risk check Compliance-first. Flat monthly fee, month to month.What does account hygiene actually mean?
In this category the phrase has been quietly repurposed to mean "spare accounts". It does not mean that, and the version that does will end the business.
| Hygiene means | It does not mean |
|---|---|
| One legal entity, one verified business manager, one ad account per platform | A second business manager held in reserve |
| A verified domain, a real physical address, named people, a working support channel | A second domain that serves a different page to reviewers |
| Payment instruments and business details that match the entity | Fresh payment instruments after an enforcement |
| One clean appeal per rejection, stating what the page says and why it is within policy | Relaunching the same creative until one copy slips through |
| Slow, deliberate scaling so enforcement risk stays proportionate to spend | Burst-launching creatives on a cold account |
| Fixing the page, then resubmitting, then waiting | Changing the destination after approval |
The right-hand column is not a list of tactics we decline to teach for tone reasons. Every item in it is described in Google's Abusing the ad network policy, which covers "Manipulation of ad components like text, image, videos, domain, or subdomains in an attempt to bypass detection or enforcement action" and "practices that circumvent or interfere with Google's advertising systems and processes, or attempting to do so". Meta's review, per its own standard, may re-review an ad after it is live.
The practical consequence: a rejection is an event, and an evasion attempt is a status. Firms survive dozens of the first. The second one is what turns a fixable creative problem into a permanently disabled asset, at which point there is no media buyer alive who can help.
Where do we stand on this?
Plainly, because this niche is full of people who will not say it.
We do not cloak. No page that shows one thing to a reviewer and another to a buyer, no redirect chains, no doorway pages, no user-agent or geography switching on the landing page.
We do not run backup accounts. One entity, one business manager, one ad account. If an account is disabled we appeal once, properly, and if the appeal fails we accept it.
We do not write copy engineered to read two ways. If a line needs a reviewer to miss the implication to survive, it is the wrong line, and we will say so rather than ship it.
We do not take on GLP-1 class compounds or PT-141, in any framing. Not as reagents, not with disclaimers, not as an ancillary product.
We will tell you the product cannot be advertised, before you pay us. Some catalogues cannot be advertised on Meta or Google in 2026 as they stand. When that is the answer, it is the answer we give, and there is no version of the engagement where we take the money and try anyway.
What is left after all of that is a real and underserved job: creative that says what the product is and nothing it is not, product pages built to survive being read as a whole, a catalogue split into what is advertisable and what is not, clean appeals, and channels outside paid social for the parts of the business that will never clear review. That is the offer on the peptides page, at a flat monthly fee, month to month.
Frequently asked questions
Can you advertise research peptides on Meta and Google in 2026?
Only as laboratory reagents sold to researchers, and only if nothing in the ad or on the landing page implies human use. Meta prohibits ads that promote the sale or use of unsafe substances, products or supplements. Google prohibits unapproved substances outright. A research use only line does not save a page that reads as a treatment.
What does Meta's advertising policy say about unsafe substances and supplements?
Meta's Drugs and Pharmaceuticals standard states that advertisers can't run ads that promote the sale or use of illicit or recreational drugs, or other unsafe substances, products or supplements, and prohibits soliciting, buying, selling, trading, donating or gifting them or encouraging their consumption. Meta's Health and Wellness standard separately prohibits claims to cure, heal or eliminate incurable diseases, and prohibits clickbait tactics in a health context such as promises of specific outcomes within a set timeframe.
What does Google's healthcare and medicines policy say?
Google's Healthcare and medicines policy routes unapproved products to its Unapproved substances policy, which states that Google doesn't allow the promotion of certain products, regardless of any claims of legality. That covers every item on a non-exhaustive published list, herbal and dietary supplements with active pharmaceutical or dangerous ingredients, products that imply they are as effective as prescription drugs or controlled substances, and products subject to a government or regulatory warning.
Does a research use only disclaimer protect a peptide seller?
No. In a warning letter dated 12 December 2025 the FDA wrote: despite statements on your product labeling marketing your products, FOR RESEARCH ONLY and NOT FOR HUMAN USE, evidence obtained from your product labeling, including your website establishes that your products are intended to be drugs for human use. Intended use is read from the whole page and the whole site, not from the disclaimer at the bottom.
Does ad review look at the landing page as well as the ad?
Yes. Meta states that its review process may include the specific components of an ad, such as images, video, text and targeting information, as well as an ad's associated landing page or other destinations. Meta also states that ads may be reviewed again, including after they are live, so a page edited after approval is re-reviewed.
What makes a research peptide product page review-safe?
Specification, not benefit. Compound identity and CAS number, purity and the analytical method behind it, molecular weight and formula, format and quantity, storage and handling, a certificate of analysis, the research use only statement above the fold rather than in the footer, and a buyer that is a laboratory or institution. No outcomes, no dosing, no administration instructions, no comparison to any approved drug, no testimonials, and nothing sold alongside it that only makes sense for injection into a person.
What does account hygiene mean for a research peptide advertiser?
One business entity, one verified business manager, one ad account per platform, a verified domain, a real physical address and named people, and one clean appeal per rejection. It never means a second account, a second domain or a second landing page used to keep running after a rejection. Google's Abusing the ad network policy states that engaging in practices that circumvent or interfere with Google's advertising systems and processes, or attempting to do so, is not allowed.
Will Wealth Marketing AI help with cloaking or backup ad accounts?
No. We do not cloak, we do not run backup accounts, we do not use redirect chains or doorway pages, and we do not write copy designed to read one way to a reviewer and another way to a buyer. We also do not take on GLP-1 class compounds or PT-141 in any framing. If a product needs a workaround to be advertised, the honest answer is that it cannot be advertised, and we say so before anyone pays us.
Method and sources
Every policy line quoted above was read from the publisher's own page on 15 September 2026 and is linked at the exact page it came from. No figure on this page is ours, and none is secondhand. Platform policies change without notice; check the links before relying on any quotation here.
- Meta, 2026. Advertising Standards, Drugs and Pharmaceuticals. Prohibition on promoting the sale or use of illicit, recreational or other unsafe substances, products or supplements; certification requirements for pharmacies, telehealth and pharmaceutical manufacturers. primarytransparency.meta.com, Drugs and Pharmaceuticals
- Meta, 2026. Advertising Standards, Health and Wellness. Prohibited cure, heal or eliminate claims; body image rules; clickbait tactics in a health context; supplement and weight-loss age restriction. primarytransparency.meta.com, Health and Wellness
- Meta, 2026. Introduction to the Advertising Standards. Scope of the standards, and the statement that review may include an ad's associated landing page or other destinations and that ads may be reviewed again after they are live. primarytransparency.meta.com/policies/ad-standards
- Google, 2026. Advertising Policies, Healthcare and medicines. Unauthorised pharmacies, unapproved substances, prescription drug services, speculative and experimental treatments, certification requirements. primarysupport.google.com/adspolicy/answer/176031
- Google, 2026. Advertising Policies, Unapproved substances. "Google doesn't allow the promotion of certain products, regardless of any claims of legality." primarysupport.google.com/adspolicy/answer/15595718
- Google, 2026. Advertising Policies, Unapproved pharmaceuticals and supplements. The illustrative, non-exhaustive product list. primarysupport.google.com/adspolicy/answer/2423645
- Google, 2026. Advertising Policies, Abusing the ad network. Evasive ad content and circumventing systems. primarysupport.google.com/adspolicy/answer/6020954
- US Food and Drug Administration, 12 December 2025. Warning letter 719337. The research use only disclaimer against website evidence, and the section 201(g)(1) intended-use test. primaryfda.gov, warning letter 719337
- US Food and Drug Administration, 24 August 2026. Warning letter 734884. Product-page claims, comparison blog posts, and ancillary products sold alongside the compound as evidence of intended human use. primaryfda.gov, warning letter 734884
- US Federal Trade Commission, 2022. Health Products Compliance Guidance. Competent and reliable scientific evidence; responsibility for implied claims; disclaimers do not cure a deceptive ad. primaryftc.gov, Health Products Compliance Guidance